Non‑Viable Particle Count

Non‑viable particle count (NVPC) is the measured concentration of airborne, nonliving particles in a controlled environment. Counts are obtained by optical light‑scattering particle counters and are typically reported per cubic meter for specified size thresholds (commonly ≥0.5 μm and ≥5.0 μm). NVPC supports cleanroom classification to ISO 14644‑1 and serves as a leading indicator of contamination control performance during operations.

Regulated manufacturers trend NVPC at risk‑based locations and frequencies aligned with EU GMP Annex 1 and FDA aseptic processing guidance for sterile operations, and with USP <797> in compounding. While NVPC does not measure microbes directly (viable counts do that), excursions often correlate with loss of contamination control, filter integrity issues, or poor aseptic behavior—triggering investigation, remediation, and potential batch impact assessments.

ISO 14644‑1 defines classification of air cleanliness by particle concentration and the methodology for determining cleanroom classes using particle counting. EU GMP Annex 1 expects continuous non‑viable monitoring in critical zones (e.g., at or near points of product exposure) and appropriately frequent monitoring in background areas, with alert/action limits justified and periodically reviewed. FDA’s aseptic processing guidance aligns cleanroom classifications with ISO 14644 and emphasizes routine monitoring that reflects actual dynamic operating conditions.

• Classification vs. monitoring: Classification verifies a room’s capability; monitoring demonstrates ongoing state of control under dynamic operations.
• Normalization: Counts must be normalized to a defined sample volume (commonly 1 m³) and particle size threshold(s).
• Response expectations: Defined alert/action limits with documented responses; immediate assessment for Grade A/B excursions in sterile manufacture.
• Program governance: Periodic review of trends, sensors/locations, and limits; linkage to risk management and HEPA/filter maintenance.

USP <797> provides additional expectations for sterile compounding environments in the U.S., including classification targets and environmental monitoring frequencies, while recognizing alignment with ISO 14644 methodologies. Together, these references define the compliance envelope against which MES implementations should be designed and validated.

Optical particle counters (OPCs) detect and size particles via light scattering. Configurations include portable units, manifolded fixed sensors, and probe‑based isokinetic sampling near critical operations. Key design variables include flow rate (e.g., 1 CFM or ~28.3 L/min), sampling duration/volume, tubing length/geometry, and probe placement relative to unidirectional airflow and interventions. For Grade A locations in aseptic operations, continuous or near‑continuous monitoring during processing is expected; background zones follow risk‑based frequencies.

• Probe placement: At points of highest risk (filling needles, open containers) without disrupting airflow patterns.
• Tubing management: Minimize bends and length to reduce particle losses; document equivalency if remote manifolds are used.
• Volume and timing: Define per‑location sample volumes and durations sufficient to detect meaningful shifts while avoiding sensor coincidence errors.
• Calibration and verification: Maintain calibrated OPCs and verify flow rate/size channel performance per manufacturer specifications; track calibration due dates in the CMMS.

Sampling plans should reflect dynamic operations—setup, routine processing, interventions, and line stoppages—and be integrated with risk assessments (e.g., ICH Q9‑aligned) to prioritize locations, frequencies, and limits. Documented rationale and periodic re‑assessment are critical for inspections.

Non‑viable particle data becomes operationally useful when contextualized by batch, equipment, area, and step. An MES at ISA‑95 Level 3 should ingest data from building management systems (BMS/EMS), OPCs (direct Ethernet/serial), historians, or manual entry, normalize to m³, time‑sync to a trusted source, and bind each record to the executing operation (e.g., Unit Procedure/Operation/Phase in ISA‑88 terms).

• Data paths: Direct device adapters, OPC UA/DA gateways, historian connectors, or structured manual entry with verification.
• Context binding: Auto‑associate records using equipment/area models and operation timestamps; reconcile gaps via review workflows.
• Time synchronization: Enforce NTP‑backed time sources to support audit trail integrity and accurate event sequencing.
• Redundancy and buffering: Implement store‑and‑forward at the edge to prevent data loss during network outages.

Alert and action limits for NVPC should be scientifically justified from classification data, historical performance, and risk. EU GMP Annex 1 expects continuous monitoring at critical Grade A locations with immediate assessment for excursions; FDA guidance emphasizes monitoring under dynamic conditions. MES should implement alarm rationalization to focus operator attention and workflow triggers for holds, line clearance, and deviation initiation.

• Statistical treatment: Particle counts are often Poisson‑like; apply appropriate charts (e.g., u‑chart) or EWMA for sensitivity to shifts.
• Normalization: Compare like‑for‑like by size channel and per‑m³ basis; document any alternate volumes.
• Alarm shelving and deadbands: Prevent alarm floods during planned transients; record shelving with rationale (review by exception).
• Root cause links: Correlate spikes with differential pressure drops, door openings, filter changeouts, or disinfection activities.

Define procedural responses for alert vs. action exceedances, including immediate area checks, verification sampling, equipment/HEPA inspection, and product impact assessments. Periodic quality review should trend NVPC alongside microbial EM, pressure, and airflow velocities to confirm a sustained state of control.

NVPC does not directly measure microbial contamination or product particulates; however, it is a critical indicator of environmental control for aseptic processing. Significant or repeated excursions in Grade A/B areas can increase risk to sterility assurance and must be investigated with documented product impact assessments as part of batch disposition.

• Holistic evaluation: Review NVPC alongside viable EM results, operator interventions, media fills, and equipment performance.
• Risk‑based decisions: Leverage predefined decision trees that align with Annex 1/FDA guidance and internal QMS procedures.
• Evidence trail: Ensure data integrity for all NVPC records used in release; retain audit trails and e‑signatures where applicable.

NVPC trends can also support continuous improvement by identifying high‑risk tasks or locations that warrant engineering controls, procedural refinement, or targeted training.

Computers and interfaces used to capture, store, and process NVPC are subject to 21 CFR Part 11 and EU Annex 11 when records support CGMP decisions. Apply GAMP 5 (2nd ed.) principles: risk‑based specification, supplier assessment, configuration control, and verification. Implement access controls (RBAC), secure time‑stamped audit trails, electronic signatures for critical actions, and backup/restore tests commensurate with risk.

• Requirements: Define user requirements for limit management, normalization, contextualization, and workflows (deviation/hold release).
• Testing: Verify data acquisition accuracy (size channels, flow/volume), normalization math, alarm logic, and Part 11 controls.
• Data lifecycle: Specify retention, archiving, and retrieval; include metadata (location, channel, volume, counter ID, calibration).
• Review by exception: Design dashboards and audit‑trail review workflows to support periodic data integrity review.

From a cybersecurity perspective, apply defense‑in‑depth (e.g., NIST SP 800‑82) for BMS/EMS connections to protect data authenticity and availability, including network segmentation, authenticated protocols, and monitored data gateways.

• Non‑normalized comparisons: Mixing volumes or size thresholds leads to false trend conclusions; always normalize to m³ and channel.
• Tubing losses and bends: Excessive tubing attenuates larger particles; validate sampling trains and document equivalency.
• Coincidence error at high loads: Counters saturate during cleaning aerosols or smoke tests; flag and exclude invalidated intervals.
• Condensation or fog: Misting disinfectants and humidity spikes can register as particles; mark planned transients with state tags.
• Time drift: Unsynchronized clocks break event correlation; enforce NTP and monitor drift.
• Alarm flood: Unrationalized alarms mask true issues; implement shelving, suppression rules, and clear response procedures.

As part of periodic management review, re‑assess sensor placement, alert/action limits, and correlation with viable EM. Document changes under change control and verify that reporting and workflows continue to meet regulatory expectations.

V5 maps particle counter inputs to areas/equipment and executing operations, auto‑normalizes counts, and enforces alert/action logic with guided operator responses. NVPC excursions can place lots or steps on electronic hold, launch deviation records, and link evidence (photos, maintenance tickets) while preserving a Part 11/Annex 11‑compliant audit trail. Dashboards trend NVPC with differential pressure and viable EM, supporting exception‑based review and management oversight.

While sterile pharmaceutical operations have the most prescriptive expectations for NVPC, other industries adapt the concept to their risk profiles. Medical device assembly in cleanrooms (e.g., implantable or sterile‑packaged devices) applies ISO classification and ongoing monitoring appropriate to product risk. Radiopharmaceutical facilities balance rapid, short‑shelf‑life production with continuous monitoring in critical hot cells and dispensing hoods.

Blood and tissue establishments monitor controlled environments to protect donor‑derived materials and processing integrity. Cosmetics facilities may employ NVPC as part of hygienic zoning for high‑risk products (e.g., eye‑area), with less stringent classes but similar principles of placement, trending, and action limits. In all cases, a documented, risk‑based rationale and periodic review are essential.

• Viable EM vs. NVPC: Viable EM detects and enumerates microorganisms (e.g., CFU via active air sampling and plates); NVPC counts nonliving particles and provides faster, continuous signals.
• USP <788> product particulates: USP <788> addresses particulate matter in injections (finished product testing), not airborne counts.
• Visual inspection: Visual inspection for visible particulates is a distinct, product‑focused control and does not replace NVPC.
• Container Closure Integrity (CCIT): CCIT evaluates package integrity; NVPC evaluates environmental cleanliness.

Programs should integrate these data streams to form a coherent contamination‑control strategy: environmental control (NVPC), microbiological state (viable EM), product‑particulate risk (USP <788>, visual inspection), and package integrity (CCIT).